+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Molecular Diagnostics Market Analysis, By Product and Service, By Technology, By Application, By End User, Forecasts to 2026

  • ID: 5206653
  • Report
  • April 2020
  • Region: Global
  • 293 pages
  • Reports and Data

FEATURED COMPANIES

  • Abbott
  • Becton
  • Bio-Rad Laboratories
  • Cepheid
  • Danaher
  • Dickinson Co.
  • MORE
The rising number of cancer cases, growing incidences of infectious diseases, robust government funding for medical science, and increasing applications of patient-specific treatments are the key factors contributing to the high CAGR of the molecular diagnostics market during the forecast period.

Market Size in 2019- USD 7.87 Billion, Market Growth - CAGR of 8.2% over the forecast period, Market Trends - Significant growth in colorectal cancer molecular diagnostics market

According to the recent analysis of Reports and Data, the Molecular Diagnostics Market size was valued at USD 7.87 Billion in 2019 and is expected to reach USD 14.94 Billion by the year 2027, registering a CAGR of 8.2%. The increasing efficiency of clinical trials, technological advancements in molecular pathology, and the growing incidence of infectious and neurological diseases are the major driving factors for the growth of the market. Expanding government aid for research and development and the establishment of advanced testing facilities is also supporting the growth of the molecular diagnostics market.

Developing economies such as India and China are facing some challenges, such as a lack of a well-built procedural system for approvals, a factor that can hinder the growth of the molecular diagnostics market in these countries. Moreover, the lack of skilled medical professionals is also restricting the growth of the market in many countries.

Further key findings from the report suggest
  • The Veterinary Molecular Diagnostics market is witnessing a booming growth as fungicidal therapies are being increasingly developed. Moreover, the development of specific assays and reagents has also contributed to the growth of the market.
  • On the basis of product and service type, the reagents and kits segment held the largest share in the market in the base year 2019. Ease of usage and the expanding applicability of reagents and kits is boosting the market growth.
  • Polymerase Chain Reaction (PCR) in the technology segment held the largest share in the global molecular diagnostics market. The penetration of technological advancements in medical science, along with the growing automation of PCR instruments, contributes to this share.
  • In Situ Hybridization is also a high growth registering technology because of the rising number of cancer cases and the resultant need for early diagnosis. Ongoing research and greater targeted funding are pushing the growth of this technology forward.
  • On the basis of application, infectious diseases form the largest segment as they make the maximum usage of Molecular Diagnostics for diagnosis and therapeutic purposes. The prevalence of infectious diseases has been increasing, and government support is strong to eliminate their spread.
  • The oncology segment, due to the extensive application of molecular diagnostics, is expected to register the highest CAGR in the forecast duration. The colorectal cancer molecular diagnostics has been registering a considerable CAGR in recent years and will continue to do so during the forecast period.
  • The instruments segment is expected to register a high CAGR during the forecast period. The demand for instruments is mainly driven by testing laboratories and clinics.
  • On the basis of end use, hospitals and academic laboratories hold the largest share in the molecular diagnostics market. Strong research-driven growth and increasing cases of diseases, especially in the geriatric population, contribute to this share.
  • By region, North America is the most developed region due to notable growth in medical science and the presence of highly skilled medical personnel. Better research funding also goes a long way in maintaining the fast pace of advancement in the field.
  • Key companies profiled in the report include Abbott, Roche Diagnostics, QIAGEN, Danaher, Hologic, Becton, Siemens Healthcare GmbH, Bio-Rad Laboratories, Dickinson and Co., and Cepheid.
Segments covered in the report:

For the purpose of this report, Reports and Data has segmented the Molecular Diagnostics Market on the basis of product and service, technology, application, end use, and region:

Product And Service Outlook (Revenue, USD Million; 2017-2027)
  • Reagents and Kits
  • Instruments
  • Services and Software
Technology Outlook (Revenue, USD Million; 2017-2027)
  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • DNA Sequencing & Next-Generation Sequencing (NGS)
  • in Situ Hybridization
  • DNA Microarray
  • Other Technologies
Application Outlook (Revenue, USD Million; 2017-2027)
  • Infectious Diseases
  • Hepatitis
  • HIV
  • CT/NG
  • HAIS
  • HPV
  • Tuberculosis
  • Influenza
  • Other Infectious Diseases
  • Oncology
  • Breast Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Cancers
  • Genetic Tests
  • Others
End Use Outlook (Revenue, USD Million; 2017-2027)
  • Hospital and Academic Laboratories
  • Reference Laboratories
  • Others
Regional Outlook (Revenue in USD Million; 2017-2027)
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Middle East and Africa
Reasons to Buy the Report
  • A robust analysis and estimation of the Molecular Diagnostics Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
  • A holistic competitive landscape of the all the major players in the Molecular Diagnostics market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
  • Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
  • Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
  • Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Becton
  • Bio-Rad Laboratories
  • Cepheid
  • Danaher
  • Dickinson Co.
  • MORE
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique

Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018 - 2026

Chapter 3. Indicative Metrics
3.1. Increasing incidence of infectious diseases
3.2. Extensive growth of medical science
3.3. Growing application of personalized medication

Chapter 4. Molecular Diagnostics Segmentation & Impact Analysis
4.1. Molecular Diagnostics Segmentation Analysis
4.2. Molecular Diagnostics Market Value Chain Analysis, 2016-2026
4.3. Regulatory framework
4.4. Molecular Diagnostics Market Impact Analysis
4.4.1. Market driver analysis
4.4.1.1. Growing research in Molecular Pathology
4.4.1.2. Rising use of High Throughput Sequencing Technologies
4.4.2. Market restraint analysis
4.4.2.1. Time-consuming Approval Mechanism
4.4.2.2. Shortage of Trained Medical Personnel
4.4.2.3. Insufficient Research Funding in Developing Economies
4.5. Key opportunities prioritized
4.6. Molecular Diagnostics Pricing Analysis
4.7. Industry analysis - Porter's
4.8. Molecular Diagnostics PESTEL Analysis

Chapter 5. Molecular Diagnostics Market By Product and Service Insights & Trends
5.1. Molecular Diagnostics Product and Service dynamics & Market Share, 2018 & 2026
5.2. Reagents and Kits
5.2.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.2.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
5.3. Instruments
5.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
5.4. Services and Software
5.4.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.4.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)

Chapter 6. Molecular Diagnostics Market By Technology Insights & Trends
6.1. Molecular Diagnostics Technology dynamics & Market Share, 2018 & 2026
6.2. Polymerase Chain Reaction (PCR)
6.2.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.2.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.3. Isothermal Nucleic Acid Amplification Technology
6.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.4. DNA Sequencing & Next-Generation Sequencing (NGS)
6.4.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.4.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.5. in Situ Hybridization
6.5.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.5.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.6. DNA Microarray
6.6.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.6.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.7. Other Technologies
6.7.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.7.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)

Chapter 7. Molecular Diagnostics Market By Application Insights & Trends
7.1. Molecular Diagnostics Application dynamics & Market Share, 2018 & 2026
7.2. Infectious Diseases
7.2.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.2.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.2.3. Hepatitis
7.2.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.2.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.2.4. HIV
7.2.4.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.2.4.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.2.5. CT/NG
7.2.5.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.2.5.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.2.6. HAIS
7.2.6.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.2.6.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.2.7. HPV
7.2.7.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.2.7.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.2.8. Tuberculosis
7.2.8.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.2.8.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.2.9. Influenza
7.2.9.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.2.9.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.2.10. Other Infectious Diseases
7.2.10.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.2.10.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.3. Oncology
7.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.3.3. Breast Cancer
7.3.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.3.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.3.4. Colorectal Cancer
7.3.4.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.3.4.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.3.5. Lung Cancer
7.3.5.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.3.5.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.3.6. Prostate Cancer
7.3.6.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.3.6.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.3.7. Other Cancers
7.3.7.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.3.7.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.4. Genetic Tests
7.4.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.4.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.5. Other Tests
7.5.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.5.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)

Chapter 8. Molecular Diagnostics Market By End User Insights & Trends
8.1. Molecular Diagnostics End User dynamics & Market Share, 2018 & 2026
8.2. Hospitals and Academic Laboratories
8.2.1. Market estimates and forecast, 2016 - 2026 (USD Million)
8.2.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
8.3. Reference Laboratories
8.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
8.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
8.4. Others
8.4.1. Market estimates and forecast, 2016 - 2026 (USD Million)
8.4.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)

Chapter 9. Molecular Diagnostics Market Regional Outlook
9.1. Molecular Diagnostics Market share by region, 2018 & 2026
9.2. North America
9.2.1. North America Molecular Diagnostics Market estimates and forecast, 2016 - 2026, (USD Million)
9.2.2. North America Molecular Diagnostics Market estimates and forecast by Product and Service Type, 2016 - 2026, (USD Million)
9.2.3. North America Molecular Diagnostics Market estimates and forecast by Technology, 2016 - 2026, (USD Million)
9.2.4. North America Molecular Diagnostics Market estimates and forecast by End User, 2016 - 2026, (USD Million)
9.2.5. North America Molecular Diagnostics Market estimates and forecast by Application, 2016 - 2026, (USD Million)
9.2.6. U.S.
9.2.6.1. U.S. Molecular Diagnostics Market estimates and forecast, 2016 - 2026, (USD Million)
9.2.6.2. U.S. Molecular Diagnostics Market estimates and forecast by Product and Service Type, 2016 - 2026, (USD Million)
9.2.6.3. U.S. Molecular Diagnostics Market estimates and forecast by Technology, 2016 - 2026, (USD Million)
9.2.6.4. U.S. Molecular Diagnostics Market estimates and forecast by End User, 2016 - 2026, (USD Million)
9.2.6.5. U.S. Molecular Diagnostics Market estimates and forecast by Application, 2016 - 2026, (USD Million)
9.2.7. Canada
9.2.7.1. Canada Molecular Diagnostics Market estimates and forecast, 2016 - 2026, (USD Million)
9.2.7.2. Canada Molecular Diagnostics Market estimates and forecast by Product and Service Type, 2016 - 2026, (USD Million)
9.2.7.3. Canada Molecular Diagnostics Market estimates and forecast by Technology, 2016 - 2026, (USD Million)
9.2.7.4. Canada Molecular Diagnostics Market estimates and forecast by End User, 2016 - 2026, (USD Million)
9.2.7.5. Canada Molecular Diagnostics Market estimates and forecast by Application, 2016 - 2026, (USD Million)
9.3. Europe
9.3.1. Europe Molecular Diagnostics Market estimates and forecast, 2016 - 2026, (USD Million)
9.3.2. Europe Molecular Diagnostics Market estimates and forecast by Product and Service Type, 2016 - 2026, (USD Million)
9.3.3. Europe Molecular Diagnostics Market estimates and forecast by Technology, 2016 - 2026, (USD Million)
9.3.4. Europe Molecular Diagnostics Market estimates and forecast by End User, 2016 - 2026, (USD Million)
9.3.5. Europe Molecular Diagnostics Market estimates and forecast by Application, 2016 - 2026, (USD Million)
9.3.6. Germany
9.3.6.1. Germany Molecular Diagnostics Market estimates and forecast, 2016 - 2026, (USD Million)
9.3.6.2. Germany Molecular Diagnostics Market estimates and forecast by Product and Service Type, 2016 - 2026, (USD Million)
9.3.6.3. Germany Molecular Diagnostics market estimates and forecast by Technology, 2016 - 2026, (USD Million)
9.3.6.4. Germany Molecular Diagnostics market estimates and forecast by End User, 2016 - 2026, (USD Million)
9.3.6.5. Germany Molecular Diagnostics market estimates and forecast by Application, 2016 - 2026, (USD Million)
9.3.7. France
9.3.7.1. France Molecular Diagnostics Market estimates and forecast, 2016 - 2026, (USD Million)
9.3.7.2. France Molecular Diagnostics Market estimates and forecast by Product and Service Type, 2016 - 2026, (USD Million)
9.3.7.3. France Molecular Diagnostics market estimates and forecast by Technology, 2016 - 2026, (USD Million)
9.3.7.4. France Molecular Diagnostics market estimates and forecast by End User, 2016 - 2026, (USD Million)
9.3.7.5. France Molecular Diagnostics market estimates and forecast by Application, 2016 - 2026, (USD Million)
9.3.8. U.K.
9.3.8.1. U.K Molecular Diagnostics market estimates and forecast, 2016 - 2026, (USD Million)
9.3.8.2. U.K Molecular Diagnostics market estimates and forecast by Product and Service Type, 2016 - 2026, (USD Million)
9.3.8.3. U.K. Molecular Diagnostics market estimates and forecast by Technology, 2016 - 2026, (USD Million)
9.3.8.4. U.K. Molecular Diagnostics market estimates and forecast by End User, 2016 - 2026, (USD Million)
9.3.8.5. U.K. Molecular Diagnostics market estimates and forecast by Application, 2016 - 2026, (USD Million)
9.3.9. Spain
9.3.9.1. Spain Molecular Diagnostics market estimates and forecast, 2016 - 2026, (USD Million)
9.3.9.2. Spain Molecular Diagnostics market estimates and forecast by Product and Service Type, 2016 - 2026, (USD Million)
9.3.9.3. Spain. Molecular Diagnostics market estimates and forecast by Technology, 2016 - 2026, (USD Million)
9.3.9.4. Spain Molecular Diagnostics market estimates and forecast by End User, 2016 - 2026, (USD Million)
9.3.9.5. Spain Molecular Diagnostics market estimates and forecast by Application, 2016 - 2026, (USD Million)
9.3.10. Italy
9.3.10.1. Italy Molecular Diagnostics Market estimates and forecast, 2016 - 2026, (USD Million)
9.3.10.2. Italy Molecular Diagnostics Market estimates and forecast by Product and Service Type, 2016 - 2026, (USD Million)
9.3.10.3. Italy Molecular Diagnostics market estimates and forecast by Technology, 2016 - 2026, (USD Million)
9.3.10.4. Italy Molecular Diagnostics market estimates and forecast by End User, 2016 - 2026, (USD Million)
9.3.10.5. Italy Molecular Diagnostics market estimates and forecast by Application, 2016 - 2026, (USD Million)
9.3.11. Rest of Europe
9.3.11.1. Rest of Europe Molecular Diagnostics market estimates and forecast, 2016 - 2026, (USD Million)
9.3.11.2. Rest of Europe Molecular Diagnostics market estimates and forecast by Product and Service Type, 2016 - 2026, (USD Million)
9.3.11.3. Rest of Europe Molecular Diagnostics market estimates and forecast by Technology, 2016 - 2026, (USD Million)
9.3.11.4. Rest of Europe Molecular Diagnostics market estimates and forecast by End User, 2016 - 2026, (USD Million)
9.3.11.5. Rest of Europe Molecular Diagnostics market estimates and forecast by Application, 2016 - 2026, (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Molecular Diagnostics market estimates and forecast, 2016 - 2026, (USD Million)
9.4.2. Asia Pacific Molecular Diagnostics market estimates and forecast by Product and Service Type, 2016 - 2026, (USD Million)
9.4.3. Asia Pacific Molecular Diagnostics market estimates and forecast by Technology, 2016 - 2026, (USD Million)
9.4.4. Asia Pacific Molecular Diagnostics market estimates and forecast by End User, 2016 - 2026, (USD Million)
9.4.5. Asia Pacific Molecular Diagnostics market estimates and forecast by Application, 2016 - 2026, (USD Million)
9.4.6. China
9.4.6.1. China Molecular Diagnostics market estimates and forecast, 2016 - 2026, (USD Million)
9.4.6.2. China Molecular Diagnostics market estimates and forecast by Product and Service Type, 2016 - 2026, (USD Million)
9.4.6.3. China Molecular Diagnostics market estimates and forecast by Technology, 2016 - 2026, (USD Million)
9.4.6.4. China Molecular Diagnostics market estimates and forecast by End User, 2016 - 2026, (USD Million)
9.4.6.5. China Molecular Diagnostics market estimates and forecast by Application, 2016 - 2026, (USD Million)
9.4.7. Japan
9.4.7.1. Japan Molecular Diagnostics market estimates and forecast, 2016 - 2026, (USD Million)
9.4.7.2. Japan Molecular Diagnostics market estimates and forecast by Product and Service Type, 2016 - 2026, (USD Million)
9.4.7.3. Japan Molecular Diagnostics market estimates and forecast by Technology, 2016 - 2026, (USD Million)
9.4.7.4. Japan Molecular Diagnostics market estimates and forecast by End User, 2016 - 2026, (USD Million)
9.4.7.5. Japan Molecular Diagnostics market estimates and forecast by Application, 2016 - 2026, (USD Million)
9.4.8. India
9.4.8.1. India Molecular Diagnostics market estimates and forecast, 2016 - 2026, (USD Million)
9.4.8.2. India Molecular Diagnostics market estimates and forecast by Product and Service Type, 2016 - 2026, (USD Million)
9.4.8.3. India Molecular Diagnostics market estimates and forecast by Technology, 2016 - 2026, (USD Million)
9.4.8.4. India Molecular Diagnostics market estimates and forecast by End User, 2016 - 2026, (USD Million)
9.4.8.5. India Molecular Diagnostics market estimates and forecast by Application, 2016 - 2026, (USD Million)
9.4.9. Rest of Asia Pacific
9.4.9.1. Rest of Asia Pacific Molecular Diagnostics market estimates and forecast, 2016 - 2026, (USD Million)
9.4.9.2. Rest of Asia Pacific Molecular Diagnostics market estimates and forecast by Product and Service Type, 2016 - 2026, (USD Million)
9.4.9.3. Rest of Asia Pacific Molecular Diagnostics market estimates and forecast by Technology, 2016 - 2026, (USD Million)
9.4.9.4. Rest of Asia Pacific Molecular Diagnostics market estimates and forecast by End User, 2016 - 2026, (USD Million)
9.4.9.5. Rest of Asia Pacific Molecular Diagnostics market estimates and forecast by Application, 2016 - 2026, (USD Million)
9.5. Middle East & Africa
9.5.1. Middle East and Africa Molecular Diagnostics market estimates and forecast, 2016 - 2026, (USD Million)
9.5.2. Middle East and Africa Molecular Diagnostics market estimates and forecast by Product and Service Type, 2016 - 2026, (USD Million)
9.5.3. Middle East and Africa Molecular Diagnostics market estimates and forecast by Technology, 2016 - 2026, (USD Million)
9.5.4. Middle East and Africa Molecular Diagnostics market estimates and forecast by End User, 2016 - 2026, (USD Million)
9.5.5. Middle East and Africa Molecular Diagnostics market estimates and forecast by Application, 2016 - 2026, (USD Million)
9.6. Latin America
9.6.1. Latin America Molecular Diagnostics market estimates and forecast, 2016 - 2026, (USD Million)
9.6.2. Latin America Molecular Diagnostics market estimates and forecast by Product and Service Type, 2016 - 2026, (USD Million)
9.6.3. Latin America Molecular Diagnostics market estimates and forecast by Technology, 2016 - 2026, (USD Million)
9.6.4. Latin America Molecular Diagnostics market estimates and forecast by End User, 2016 - 2026, (USD Million)
9.6.5. Latin America Molecular Diagnostics market estimates and forecast by Application, 2016 - 2026, (USD Million)
9.6.6. Brazil
9.6.6.1. Brazil Molecular Diagnostics market estimates and forecast, 2016 - 2026, (USD Million)
9.6.6.2. Brazil Molecular Diagnostics market estimates and forecast by Product and Service Type, 2016 - 2026, (USD Million)
9.6.6.3. Brazil Molecular Diagnostics market estimates and forecast by Technology, 2016 - 2026, (USD Million)
9.6.6.4. Brazil Molecular Diagnostics market estimates and forecast by End User, 2016 - 2026, (USD Million)
9.6.6.5. Brazil Molecular Diagnostics market estimates and forecast by Application, 2016 - 2026, (USD Million)

Chapter 10. Competitive Landscape
10.1. Market Revenue Share by Manufacturers
10.2. Manufacturing Cost Breakdown Analysis
10.3. Mergers & Acquisitions
10.4. Strategy Benchmarking
10.5. Vendor Landscape

Chapter 11. Company Profiles
11.1. Abbott
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Length Benchmarking
11.1.4. Strategic Initiatives
11.2. Roche Diagnostics
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Length Benchmarking
11.2.4. Strategic Initiatives
11.3. QIAGEN
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Length Benchmarking
11.3.4. Strategic Initiatives
11.4. Danaher
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Length Benchmarking
11.4.4. Strategic Initiatives
11.5. Hologic
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Length Benchmarking
11.5.4. Strategic Initiatives
11.6. Becton
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Length Benchmarking
11.6.4. Strategic Initiatives
11.7. Siemens Healthcare GmbH
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Length Benchmarking
11.7.4. Strategic Initiatives
11.8. Bio-Rad Laboratories
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Length Benchmarking
11.8.4. Strategic Initiatives
11.9. Dickinson and Co.
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Length Benchmarking
11.9.4. Strategic Initiatives
11.10. Cepheid
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Length Benchmarking
11.10.4. Strategic Initiatives
Note: Product cover images may vary from those shown
  • Abbott
  • Roche Diagnostics
  • QIAGEN
  • Danaher
  • Hologic
  • Becton
  • Siemens Healthcare GmbH
  • Bio-Rad Laboratories
  • Dickinson Co.
  • Cepheid
Note: Product cover images may vary from those shown
Adroll
adroll